Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2024)

Quantum Biopharma has reported Cash from Discontinued Operations for 4 years, with the latest figure at 504264.0 in Q1 2022.

• Quarterly Cash from Discontinued Operations fell 175.04% year-over-year to 504264.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 2558318.0 (down 1670.73% YoY) and the FY2022 annual result came in at 1142982.0, up 17.3% from the prior year.
• Cash from Discontinued Operations climbed to 504264.0 in Q1 2022 per QNTM's latest filing, from 2608536.0 in the prior quarter.
• Over five years, Cash from Discontinued Operations peaked at 1539547.64 in Q1 2019 and troughed at 2608536.0 in Q4 2021.
• A 4-year average of 35838.62 and a median of 141551.32 in 2020 frame the typical range for Cash from Discontinued Operations.
• The sharpest annual moves came in 2020 and 2021: Cash from Discontinued Operations sank 194.75% in 2020, then soared 930.31% in 2021.
• Over 4 years, Cash from Discontinued Operations stood at 497509.96 in 2019, then sank by 91.32% to 43193.64 in 2020, then tumbled by 6139.17% to 2608536.0 in 2021, then surged by 80.67% to 504264.0 in 2022.
• According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 504264.0, 2608536.0, and 314573.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.